News, events and information for our growing community.
Our patients are like family. Each time we see you, we try our best to keep up with what's happening in your life. And we'd love to continue to share what's going on in ours.
Statement from Boston Paincare Center
The Massachusetts Department of Public Health is collaborating with the CDC, FDA, and other state public health officials to identify the cause of an outbreak of more than 25 suspected cases of aspergillus (fungal) meningitis under investigation in Florida, Maryland, North Carolina, Tennessee and Virginia. The cause for this cluster of cases is not yet known. One medication, Methylprednisolone Acetate, a steroid, was prepared at the New England Compounding Center, Inc (NECC), a pharmacy in Framingham, Massachusetts. It has been recalled and quarantined as a precaution. NECC is voluntarily recalling all similar medications.
It is imperative that you know that we do not get our steroids from any compounding specialty pharmacy. Our steroids that are used at Boston Paincare Center are bought from Pfizer Pharmaceutical Company. There is no reason to suspect that there is any danger from the steroids that we receive from Pfizer. If you have any questions regarding this outbreak please ask one of our medical personnel on staff. The form of fungal meningitis in these patients is not transmitted from person to person. There are no known cases in Massachusetts.
Dr. Zahid Bajwa appointed Director of the newly established Headache Institute at Boston PainCare
Dr. Bajwa is recognized nationally as one of the leading pain and headache specialists in the country and joins the staff at BPC after a distinguished 18 year career at the Beth Israel Deaconess Medical Center. After completing his neurology residency at Albert Einstein College of Medicine and Montefiore Hospital in New York, Dr. Bajwa completed a pain medicine fellowship at the Massachusetts General Hospital and Harvard Medical School in 1993. Dr. Bajwa was instrumental in advancing the pain medicine program at Beth Israel and his list of achievements include the founding of the first Headache Center and the first Cancer Pain Service at BIDMC.
His career is also distinguished by his commitment to pain medicine education and research. He has trained pain medicine fellows at BIDMC and Harvard Medical School since 1993. Dr. Bajwa pioneered the Harvard Medical School pain course “Principles and Practice of Pain Medicine”, and most recently has served as the Director of Education and Clinical Pain Research at BIDMC. He is also a lead author of one of the most authoritative and widely read pain medicine text books “Principles and Practices of Pain Medicine” and has been the principle investigator for numerous pain related studies. Dr. Bajwa holds leadership roles both regionally and nationally. He currently serves as Secretary of the American Academy of Pain Medicine, and is an ad hoc reviewer for Pain Medicine, the New England Journal of Medicine, the Journal of Pain and Symptom Management, and Anesthesia and Analgesia.
Dr. Bajwa brings to Boston PainCare Center a unique skill set as a physician trained and board certified in both neurology and pain management. Together with Boston PainCare’s integrative and interdisciplinary approach to pain management, the newly founded Headache Institute lead by Dr. Bajwa will be one of the most comprehensive and unique headache programs in the region.
The Headache Institute at Boston PainCare
is accepting new patients.